the aid library

LIST OPTIONS

Filter

2502

Sort by:

Direction:

Download (1302)

View PDF (5060)

Haiti Cholera Training Manual: A Full Course for Healthcare Providers

Ministry of Health and Population in HaitiU.S. Centers for Disease Control and Prevention (2011)

Download (540)

View PDF (1035)

Guidelines on the Management of Sexually‐Transmitted Infections (STI) In Pregnancy

National Center for Disease Prevention and Control Department of Health, Philippines (2010) C1

Download (915)

View PDF (946)

Malawi National Health Indicators

Ministry of Health, Malawi; CENTRAL MONITORING A ND EVALUATION DIVISI ON (CMED) (2015) C1

Draft version

Download (4331)

View PDF (2174)

Public Health Emergency Management Guidelines for Ethiopia 2012

Ethiopian Health and Nutrition Research Institute Public Health Emergency Management Centre (2012) C1

Download (256)

View PDF (517)

Review of the national tuberculosis programme in Romania

P. de Colombani, V. Hollo, N. Jansen, et al. World Health Organization; European Centre for disease prevention and Control (2015) C_WHO

10–21 March 2014

Download (295)

View PDF (497)

CDC in Mozambique (Factsheet)

Center for Disease Control and Prevention (CDC) (2013) C1

This factsheet describes the work and activities of the Center for Disease Control and Prevention (CDC) in Mozambique as well as its impact in this country.

Download (1741)

View PDF (3168)

National Communication Strategy for Ebola response in Sierra Leone

Ministry of Health and Sanitation Sierra Leone (2014)

Download (1161)

View PDF (2238)

Guideline for Hand Hygiene in Health-Care Settings

Centers for Disease Control and Prevention CDC (2002)

Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force

Download (365)

View PDF (353)

Geographical distribution of areas with a high prevalence of HTLV-1 infection

European Centre for Disease Prevention and Control (ECDC) (2015) C1

ECDC Technical Report
In line with ECDC’s recommendations provided in the ’Risk Assessment of HTLV-1/2 transmission by tissue/cell transplantation’ dated 14 March 2012, this Directive replaces the term ‘incidence’ with ‘prevalence’ in the description of endemic areas of HTLV-1/2 i... more

Download (786)

View PDF (1073)

Understanding Ebola: the 2014 epidemic

J. Kaner and S.Schaack (2016) CC

Globalization and Health201612:53 DOI: 10.1186/s12992-016-0194-4

Download (207)

View PDF (1904)

Cervical cancer in Zimbabwe: a situation analysis
recommended

Oppah Kuguyo, A. Matimba, Nomsa Tsika, et al. African Field Epidemiology Network (AFENET) (2017) CC

Pan African Medical Journal 2017;27:215. doi: 10.11604/pamj.2017.27.215.12994

Download (529)

View PDF (638)

Operational Plan Communicable Disease Control July 2011-June 2016

Ministry of Health and Family Welfare Government of the People's Republic of Bangladesh (2011) C1

Download (96)

View PDF (157)

Maldives National Action Plan for Containment of Antimicrobial Resistance 2017-2022

Maldives Food and Drug Authority Ministry of Health (2017) C2

Maldives has made significant strides in the area of infectious disease prevention and control. This is exemplified by elimination of malaria from Maldives in 2015 and successes in TB control. In addition, Maldives is a front runner in infectious disease prevention through successful water, sanitati... more

Download (128)

View PDF (145)

National Action Plan of the Islamic Republic of Iran for combating antimicrobial resistance

Ministry of Health and Medical Education Iran (2016) C_WHO

Antimicrobial resistance is one of the most important threats to the health worldwide. Antimicrobial resistance or drug resistance is the reduction of the pharmaceutical effects of a drug against a disease or reduction of its effectiveness in improving the clinical signs of a disease. Antimicrobial ... more

Download (150)

View PDF (175)

Guidelines for the implementation of non-pharmaceutical interventions against COVID-19

European Centre for Disease Prevention and Control ECDC (2016) C1

Non-pharmaceutical interventions (NPI) are public health measures that aim to prevent and/or control SARS-CoV-2 transmission in the community. As long as there is no effective and safe vaccine to protect those at risk of severe COVID-19, NPI are the most effective public health interventions against... more

Download (183)

View PDF (232)

The European Union One Health 2020 Zoonoses Report

European Centre for Disease Prevention and Control ECDC; EFSA EFSA Journal (2021) CC

This report of the EFSA and ECDC presents the results of zoonoses monitoring activities carried out in 2020 in 27 EU Member States (MS) and nine non-MS. Key statistics on zoonoses and zoonotic agents in humans, food, animals and feed are provided and interpreted historically.

Download (156)

View PDF (210)

2nd International Conference on Re-emerging Infectious Diseases: Scientific Report

African Union; Africa CDC Centres for Disease Control and Prevention Africa CDC (2019) C_CDC

In 2007, WHO warned that infectious diseases are emerging and re-emerging at a rate that has not been seen before. The potential for infectious diseases to spread rapidly results in high morbidity and mortality, causing a potential global public health treat of major concern. Several factors are ... more

Download (110)

View PDF (163)

Chagas disease key facts

International Federation of Red Cross and Red Crescent Societies IFRC IFRC (2022) C1

About six to seven million people worldwide, mostly in Latin America, are estimated to be infected with Trypanosoma cruzi, the parasite that causes Chagas disease (WHO data from 2021). Chagas disease is found mainly in endemic areas of 21 Latin American countries. Chagas disease was once entirely ... more

Download (85)

View PDF (473)

Progress Toward Global Eradication of Dracunculiasis

Hopkins, D.; Weiss, A.; Roy, S. et al. Morbidity and Mortality Weekly Report MMWR; National Libary of Medicine (2020) CC

Dracunculiasis (Guinea worm disease), caused by the parasite Dracunculus medinensis, is traditionally acquired by drinking water containing copepods (water fleas) infected with D. medinensis larvae, but in recent years also appears increasingly to be transmitted by eating fish or other aquatic anima... more

Download (7)

View PDF (6)

Mpox Testing Strategy - November 2024

Africa Center for Disease Control and Prevention (2024) CC

Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde...d in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries. In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response. As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa. more

Cervical cancer in Zimbabwe: a situation analysis recommended

Cervical cancer in Zimbabwe: a situation analysis
recommended